Argos Therapeutics Inc (NASDAQ:ARGS)

7.87
Delayed Data
As of May 22
 +0.24 / +3.15%
Today’s Change
5.61
Today|||52-Week Range
10.80
-21.30%
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close7.63
Today’s open7.60
Day’s range7.60 - 7.92
Volume91,672
Average volume (3 months)27,357
Market cap$162.8M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+87.30%
Earnings growth (this year)-0.32%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.36%
P/E ratioNM
Price/Sales87.98
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc-0.08-0.91%
CERUCerulean Pharma Inc+0.01+0.16%
RDHLRedhill Biopharma Lt...-0.17-1.05%
EGLTEgalet Corp-0.07-0.77%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$2.0M
Annual profit (last year)-$53.3M
Net profit margin-2,700.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Operating Officer &
VP-Manufacturing
Frederick M. Miesowicz
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers